Skip to main content

Table 1 Timeline of case 1

From: Surgical debridement of corneal shield ulcers in pediatric patients: two case reports and a review of the literature

Timeline

Description of the presentation and follow-up

Duration of topical medication and ulcer resolution

Day 1

Patient with grade 2 shield ulcer in the right eye. Treatment with prednisolone acetate 1% twice daily and epinastine hydrochloride 0.05 mg/ml eye drops twice daily

Start of assistance with topical medication

Day 7

No improvement in the shield ulcer

Maintenance of topical medication

Day 28

Slight reduction in the shield ulcer. Surgical removal of the plaque was indicated. Lost contact with the patient

After 28 days, the assistance was interrupted for 104 days

Day 118

Return of the patient. Treatment with prednisolone acetate 1% twice daily and epinastine hydrochloride 0.05 mg/ml eye drops twice daily

Restart of topical medication for 14 days prior to surgery

Day 132

Surgical debridement was performed. Occlusive dressing with ciprofloxacin hydrochloride ointment (3.5 mg/g) and dexamethasone (1.0 mg/g) was applied for a week

New topical medication for 7 days after surgery and ulcer resolution in this period

Day 139

Completely re-epithelialized cornea with a diffuse anterior stromal haze. Treatment with prednisolone acetate 1% every 2 days in both eyes and epinastine hydrochloride 0.05% twice daily

Topical treatment changed and maintained for 45 days

Day 184

Diffuse anterior stromal haze in the area of the previous ulcer. Treatment with tacrolimus 0.02% twice daily in both eyes and epinastine hydrochloride 0.05% twice daily in both eyes

Topical medication maintained for another 2 months

Month 8

Diffuse anterior stromal haze, with no signs of ulcer. Clinical treatment maintained

Topical treatment maintained